CTXR
Citius Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$0.75
+0.04 (+6.00%)
Open$0.77
Previous Close$0.71
Day High$0.77
Day Low$0.70
52W High$5.15
52W Low$3.37
Volume—
Avg Volume492.0K
Market Cap15.67M
P/E Ratio20.67
EPS$0.18
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+410.1% upside
Current
$0.75
$0.75
Target
$3.85
$3.85
$3.27
$3.85 avg
$6.37
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.36M | 3.56M | 3.14M |
| Net Income | 635.6K | 690.8K | 743.5K |
| Profit Margin | 18.9% | 19.4% | 23.7% |
| EBITDA | 1.24M | 1.20M | 1.26M |
| Free Cash Flow | 627.5K | 529.6K | 500.9K |
| Rev Growth | -2.5% | +1.7% | -0.7% |
| Debt/Equity | 1.45 | 1.39 | 1.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |